Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
173M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
+14.4M
-
Total reported value, excl. options
-
$343M
-
Value change
-
+$343M
-
Number of buys
-
38
-
Price
-
$23.79
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q1 2023
40 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q1 2023.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 173M outstanding shares and own 8.35% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (2.65M shares), BVF INC/IL (1.75M shares), FMR LLC (1.25M shares), FEDERATED HERMES, INC. (1.05M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (940K shares), PRICE T ROWE ASSOCIATES INC /MD/ (787K shares), Casdin Capital, LLC (677K shares), T. Rowe Price Investment Management, Inc. (598K shares), Cormorant Asset Management, LP (576K shares), and BlackRock Inc. (400K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.